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The Journal of Immunology
CD4+ T Cell Responses to the Plasmodium falciparum
Erythrocyte Membrane Protein 1 in Children with Mild
Malaria
Evelyn N. Gitau,*,† James Tuju,* Henry Karanja,* Liz Stevenson,*,1 Pilar Requena,†
Eva Kimani,* Ally Olotu,* Domtila Kimani,* Kevin Marsh,*,‡ Peter Bull,*,‡ and
Britta C. Urban*,†
The immune response against the variant surface Ag Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a key
component of clinical immunity against malaria. We have investigated the development and maintenance of CD4+ T cell responses
to a small semiconserved area of the Duffy binding–like domain (DBL)a–domain of PfEMP1, the DBLa-tag. Young children were
followed up longitudinally, and parasites and PBMCs were isolated from 35 patients presenting with an acute case of uncompli-
cated malaria. The DBLa-tag from the PfEMP1 dominantly expressed by the homologous parasite isolate was cloned and
expressed as recombinant protein. The recombinant DBLa-tag was used to activate PBMCs collected from each acute episode and
from an annual cross-sectional survey performed after the acute malaria episode. In this article, we report that CD4+ T cell
responses to the homologous DBLa-tag were induced in 75% of the children at the time of the acute episode and in 62% of the
children at the following cross-sectional survey on average 235 d later. Furthermore, children who had induced DBLa-tag–specific
CD4+IL-4+ T cells at the acute episode remained episode free for longer than children who induced other types of CD4+ T cell
responses. These results suggest that a wide range of DBLa-tag–specific CD4+ T cell responses were induced in children with mild
malaria and, in the case of CD4+IL-4+ T cell responses, were associated with protection from clinical episodes. The Journal of
Immunology, 2014, 192: 1753–1761.
C
linical immunity to malaria requires the induction of both
Ag-specific T cell and B cell responses (reviewed in Ref. 1).
Ag-specific T cells not only provide T cell help to B cells
but also activate the cellular arm of immune responses. One important
target of humoral immunity is the Plasmodium falciparum erythro-
cyte membrane protein 1 (PfEMP1), which mediates sequestration of
mature forms of the parasite in the vascular bed (2). PfEMP1 is
encoded by ∼60 var genes per haploid genome that undergo clonal
antigenic variation (3). Variants of PfEMP1 mediate adhesion to
host receptors such as CD36, ICAM-1, CR1 expressed on endothelial
cells, RBCs, and leukocytes, and some variants mediate rosetting of
infected RBCs (iRBCs) with uninfected RBCs. Adhesion of mature
forms of asexual iRBCs and rosetting in postcapillary venules can
lead to obstruction of capillaries with local hypoxia and tissue
damage (4).
Recently, var genes encoding PfEMP1 from fully sequenced lab-
oratory and clinical parasite isolates have been grouped according
to the upstream promoter sequence, chromosomal orientation, and
position of var genes as well as their adhesion characteristics (5–7).
Group A and group B/A PfEMP1 constitute an antigenically re-
stricted subset, and their expression appears to be associated with
severe malarial disease (8–15). However, the wide sequence het-
erogeneity of PfEMP1 variants has rendered analysis of expression
patterns on clinical isolates difficult. Bull and colleagues (16) de-
veloped a sequence classification system based on a region of the
Duffy binding–like domain (DBL)a–domain of PfEMP1, the DBLa-
tag, which can be amplified from var genes using universal PCR
primers and thus is accessible in clinical isolates. The amino acid
sequence of amplified DBLa-tags can be grouped according to the
number of cysteines (cys2 or cys4), the presence of sequence sig-
natures at “Positions of Limited Variation” (PoLV), and through
sharing of a limited number of sequence blocks within the hyper-
variable regions (17). The majority of group A and group B/A
PfEMP1 belong to the group of cys2 PfEMP1. Expression of
different subsets of cys2 PfEMP1 has been associated with distinct
clinical syndromes and low Ab levels in children suffering from
severe malaria (10–13, 16, 18). Clinical immunity to malaria is
associated with the accumulation of a wide range of Abs specific
for different PfEMP1 variants (12, 19–21). Much less is known about
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the specificity and phenotype of CD4+ T cell responses to PfEMP1,
partly because the extreme sequence variability poses a challenge for
the analysis of variant-specific T cell responses. Previous studies
using recombinant proteins or peptides based on PfEMP1 expressed
on laboratory lines showed that individuals living in malaria-
endemic areas harbored both IFN-g2 and IL-10–secreting Ag-
specific CD4+ T cells (22, 23). To identify CD4+ T cell responses
to PfEMP1 children had encountered during an acute malaria epi-
sode, we expressed DBLa-tags representing the dominant PfEMP1
on a parasite isolate and stimulated PBMCs from the child who
donated the parasites with this homologous DBLa-tag. Using this
system, we showed that DBLa-tag–specific T cells are readily
detected in children with acute malaria and maintained for up to
16 wk after an acute episode in a proportion of children (24). The
phenotype of CD4+ T cell responses to DBLa-tags did not differ
between children suffering from severe malaria and those with
mild malaria. However, children responding to a homologous cys2
DBLa-tag induced IL-10–secreting CD4+ T cells during acute
disease but IFN-g–secreting CD4+ T cells 16 wk after an acute
malaria episode, suggesting that a stable population of effector
memory Th1 cells was maintained.
We wondered whether the phenotype of CD4+ T cell responses
to DBLa-tags to which a child had been exposed was associated
with protection from future malaria episodes. We therefore ana-
lyzed CD4+ T cell responses to homologous DBLa-tags in a co-
hort of children under active surveillance for acute malaria episodes.
We expressed the homologous DBLa-tag representing the dominant
expressed PfEMP1 on infected erythrocytes from 35 children with
mild malaria as recombinant proteins. We used the recombinant,
homologous DBLa-tag that originated from infected erythro-
cytes isolated from a given child to investigate the phenotype of
Ag-specific CD4+ T cells of that child during and after the acute
episode. Thus, PBMCs from each child were activated with the
recombinant DBLa-tag they had encountered during acute dis-
ease. We confirmed that cys2 DBLa-tags induced CD4+ T cells
that predominantly secrete IL-10 during the acute malaria epi-
sode. Of interest, we observed that DBLa-tag–specific CD4+IL-4+
T cells were associated with delayed time to subsequent malaria
episode over a period of 1 y, suggesting a possible role for IL-4–
secreting CD4+ T cells in protection.
Materials and Methods
Study cohort
To test CD4 T cell responses to PfEMP1, parasites and PBMCs were
isolated from 35 children under active surveillance for acute malaria se-
lected from a cohort of ∼300 children in Junju, Kilifi District in the Coastal
Province of Kenya (25). The inhabitants of Junju are predominantly of the
Mijikenda ethnic group and are exposed to biannual peaks of malaria
transmission in November–December and May–July. Low-level transmission
is also known to occur throughout the year (26). In this population, infection
with gastrointestinal helminths can be detected in ∼25% of children but does
not alter susceptibility to malaria (27). Acute malaria was defined as an
axillary temperature of $ 37.5˚C and P. falciparum parasite density of $
2500 parasites per microliter of blood. Children who were acutely ill re-
ceived medical treatment as required. Between May 2008 and May 2009,
362 children were registered in the cohort, and of these 230 children had at
least one acute malaria episode. As part of a larger study, cytoadhesion of
infected erythrocytes to CD36 and ICAM-1 was carried out on 95 clinical
parasite isolates from children presenting with an acute malaria episode (28).
We identified the dominant DBLa-tag representing PfEMP1 expressed on
clinical parasite isolates from 50 of these children and were able to express
these DBLa-tags as recombinant protein from clinical parasite isolates of 36
children. For 33 children under investigation, PBMCs were collected during
the cross-sectional survey in May 2009. Ten of these children had circulating
parasites in their blood but did not show any clinical symptoms.
Parents or guardians of the children provided written informed consent.
The study was approved by the Kenyan National Ethics Review Committee
(SSC no. 1131) and the Oxford Tropical Research Ethics Committee
(protocol no. 30-06).
Processing of blood samples
Blood samples were collected and processed as described previously (24).
PBMCs were resuspended in 10% DMSO/FCS and stored in liquid ni-
trogen, and plasma was stored at 280C. In addition, 100 ml packed RBCs
was resuspended in 800 ml TRIzol and stored at 280˚C for extraction of
RNA.
Isolation and expression of dominant expressed DBLa-tag
Dominant expressed PfEMP1 were identified by the method described in
detail elsewhere (17), with variations described in Ref. 24. In brief, total
RNA was extracted from clinical parasite isolates, using TRIzol, and was
reversed transcribed to cDNA. The DBLa-tag was amplified with universal
primers targeting semiconserved areas of the DBLa-domain of PfEMP1
[DBLaAF9: 59-GCACG(A/C)AGTTT(C/T)GC-39; DBLaBR: 59-GCCCAT-
TC(G/C)TCGAACCA-39]. The PCR products were cloned into pCR2.1
TOPO cloning vectors, and plasmids from 10 to 20 colonies were isolated.
Individual plasmids were sequenced using Big Dye Terminator v3.1 cycle
sequencing on an Applied Biosystems 3730 capillary sequencer. The dom-
inant expressed DBLa-tag was identified for each clinical parasite isolate,
amplified using the DBLaAF primer and the DBLaBR primer with an
additional stop codon, and ligated into the pEXP5(NT) TOPO vector
containing an N-terminal His-tag. Plasmids containing the correct sequence
were transformed into BL21 DE3pLys Escherichia coli, and individual
colonies were grown to an OD of 0.4 before induction of protein expression
with 1 mM isopropyl b-D-thiogalactoside. Cells were lysed with BugBuster
NT containing Benzonase, and recombinant proteins were purified under
denaturing conditions using Probond Nickel-Chelating Resin according
to the manufacturer’s recommendation. Purified proteins were refolded
by dialysis against 20 mM Tris HCl, 50 mM NaCl, and 6 M urea, pH 4.5,
with stepwise reduction of the urea concentration over a period of 36 h.
Endotoxin was removed using Endotrap Blue according to the manufacturer’s
recommendation, and endotoxin removal was verified using a Limulus
amoeba lysate assay. The protein concentration was determined with the
BCA assay. Using a classification system previously described, we grouped
the recombinant DBLa-tags (European Molecular Biology Laboratory ac-
cession numbers HE863905–HE863940; http://www.ebi.ac.uk/embl/) accord-
ing to the number of cysteines found in their sequence (16).
Intracellular cytokine staining
PBMCs from acute (36 children) and cross-sectional samples (33 children)
were thawed, and 0.5 3 106 cells were seeded two times in triplicate into
96-well plates in medium (RPMI 1698 supplemented with 5% pooled
human AB serum, 5 mM glutamine, 10 mM HEPES, 50 mM 2-MΕ, and 50
mM kanamycin). Cells were rested overnight before activation with me-
dium alone, 20 mg/ml homologous recombinant DBLa-tag (isolated from
infected erythrocytes with which the child was infected during acute dis-
ease), or anti-CD2/CD3/anti-CD28–coated MACSiBead Particles (Milte-
nyi Biotec) in the presence of 1 mg/ml CD28 and CD49d for 2 h. Cells
were incubated for another 18 h in the presence of brefeldin A. Cells were
harvested and stained with ViViD Aqua (Invitrogen) before intracellular
cytokine staining was performed as follows: Cells were fixed with Cytofix
(Becton Dickinson) for 20 min at room temperature in the dark, washed
twice with Cytoperm (Becton Dickinson), and subsequently stained in
Cytoperm with CD3-ECD (Beckman Coulter), CD4-PerCP (Becton Dick-
inson), CD8-APC H7 (Becton Dickinson), IL-2–FITC (Becton Dickinson),
IL-10–PE (Becton Dickinson), IFN-g–PECy7 (Becton Dickinson), and IL-
4–APC (Becton Dickinson), for 1 h at 4˚C in the dark. Cells were washed
twice and resuspended in Sheath Fluid (Beckman Coulter), and $ 100,000
lymphocytes were acquired on a Cyan Analyzer (Beckman Coulter) within
24 h. Single stained BD comp beads were processed and acquired in
parallel to PBMC samples each day and used to set postacquisition com-
pensation in FlowJo. Live CD3+CD4+ or CD3+CD8+ T cells were identi-
fied, and the proportion of intracellular cytokine-producing T cells was
determined using FlowJo Africa. Samples with , 1000 CD4+ T cells (n = 1
acute episode and n = May 7, 2009 cross-sectional survey) were excluded
from further analysis. Thus, data presented in this article were available for
35 children with acute malaria and 26 children during the cross-sectional
survey in May 2009. The median CD4+ T cell count acquired in the remaining
samples was 50,760 CD4+ T cells (range: 2321–230,000). Values obtained
from PBMCs incubated with medium alone were subtracted from values
obtained after activation of PBMCs with DBLa-tags. When individual
gates of cytokine-secreting CD4+ T cells had fewer than five positive
events or their percentage was ,0.03%, the response was recorded as zero.
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The gating strategy for one representative sample is shown in Supplemental
Fig. 1. Because the background of CD4+IL-4+ T cell responses was high in
medium control samples of some children, we tested the specificity of our
IL-4 Ab. When we replaced the anti–IL-4–APC Ab with an isotype control
Ab or blocked IL-4 with an unconjugated anti–IL-4 Ab, almost no back-
ground staining was observed (Supplemental Fig. 2).
ELISA
Plasma cytokine concentrations for TNF-a, IL-12, IL-10, TGF-b, IFN-g,
and IL-4 were determined using commercially available ELISA kits (R&D
Systems, Minneapolis, MN, TNF-a and BD Sciences, San Jose, CA, for all
other cytokines). The ELISAs were performed according to the manu-
facturers’ instructions. The detection limits for all cytokines was at or
below 20 pg/ml.
For Ab reactivity in sera against DBLa-tags, ELISA plates (MaxiSorp;
Nunc) were coated with 1 mg/ml individual DBLa-tags diluted in PBS
overnight at 4˚C. Plates were washed three times with PBS and then
blocked with 3% BSA (Sigma-Aldrich) diluted in PBS and 0.01% Tween
20 (VWR) for 2 h at room temperature. Plates were washed three times
with PBS and 0.01% Tween 20 and incubated in duplicate with a 1:200
dilution of individual patient serum diluted in 3% BSA, PBS, and 0.01%
Tween 20 for 2 h at room temperature. Each DBLa-tag was also tested
against sera from five European donors not exposed to malaria and five
hyperimmune donors. Plates were washed three times, as before, and
subsequently incubated with rabbit anti-human IgG conjugated to HRP
(DAKO Cytomation) diluted 1:5000, anti-human IgG4 (Southern Biotech),
or anti-human IgE (Southern Biotech), 1:125 in 3% BSA, PBS, and 0.01%
Tween 20 for 1 h at room temperature. Plates were washed three times, as
FIGURE 1. Schematic presentation of the study design. From each child, blood samples were collected at the acute malaria episode or during the cross-
sectional survey (postacute). PBMCs and plasma were separated and stored. RBCs were separated from the acute blood sample and total parasite RNA
isolated using Trizol. Total RNA was reversed transcribed and DBLa-tag sequences amplified by PCR. DBLa-tag PCR products were cloned and 10–20
clones sequenced. The dominant DBLa-tag sequence was cloned into an expression vector and the recombinant DBLa-tag purified. The recombinant
DBLa-tag originating from PfEMP1 expressed on the clinical parasite isolate a child was infected with (the homologous DBLa-tag) was used to stimulate
stored PBMCs from that child and CD4+ T cell responses were analyzed by intracellular cytokine staining and flow cytometry.
FIGURE 2. Cumulative percentage of cytokine
producing CD4+ T cells after stimulation with
homologous DBLa-tag. Shown are cumulative bar-
graphs of the percentage of DBLa-tag specific
CD4+ T cells producing cytokines as indicated for
each child at the acute episode (A) and at the
cross-sectional survey (B). Children with asymp-
tomatic parasitaemia at the cross-sectional survey
are indicted (*). Children with missing data at the
cross-sectional survey (n = 9) are also indicated
(x).
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before, and developed with OPD (Sigma-Aldrich) for 20–30 min, and the
OD was measured at 490 nm.
Statistical data analysis
Mean responses were calculated, and a Student t test was conducted for
normally distributed variables. Median responses were calculated, and the
Wilcoxon rank sum test was conducted for variables with a nonnormal
distributions. Logistic regression was used to examine independent rela-
tionships of dominant expression of cys2- and cys4-PfEMP1 on a given
clinical isolate, and the phenotype of the CD4+ T cell response at the acute
episode was adjusted for both age and parasite density. To analyze whether
the phenotype of the CD4+ T cell response at the acute episode conferred
protection over 1-y of follow-up, Cox regression with the primary endpoint
of time to next episode of clinical malaria after the acute event was used
and adjusted for age at time of acute illness. Stata version 11.2 and R
version 2.11.1 were used for statistical analysis. Graphs were generated
using Stata version 11.2 and GraphPad Prism version 5.0.
Results
Phenotype of T cell responses to PfEMP1 during the acute
malaria episode
We analyzed CD4 T cell responses to the recombinant homologous
DBLa-tags representing the dominant expressed PfEMP1 on each
clinical isolate from 35 children presenting with an acute episode
between May 2008 and May 2009 (a schematic overview is pre-
sented in Fig. 1). Overall, cytokine-secreting, Ag-specific CD4+
T cells were detected in 27 (75%) children in response to the
DBLa-tag at the acute episode (Fig. 2). There were no significant
differences in either parasite densities, age, WBC counts, eosin-
ophil counts or hemoglobin levels in children with or without Ag-
specific CD4+ T cell responses at the time of acute disease (Table
I). Although infection with gastrointestinal helminths was not mea-
sured but is known to be prevalent in this area, none of the children
showed mild eosinophilia (median (25th and 75th percentile): 0.123
103/ml (0.06–0.15 3 103/ml) suggesting that acute infection with
gastrointestinal helminths can be excluded. In addition, we measured
the concentration of proinflammatory and anti-inflammatory cyto-
kines in plasma (Supplemental Fig. 3). The number of children with
detectable levels of TNF-a (n = 4) and IL-4 (n = 5) was low. Overall,
cytokine levels did not differ significantly between those children
who showed Ag-specific CD4+ T cell responses and those who did
not.
During acute disease, 12 (34.3%) children had DBLa-tag spe-
cific IFN-g+ CD4+ T cells either alone or in the presence of CD4+
T cells secreting other cytokines. Of these 12 children, 5 also
induced DBLa-tag specific IL-10+ CD4+ T cells and 2 children
induced IFN-g+IL-10+ double producing CD4+ T cells. To define
the phenotype of DBLa-tag specific CD4+ T cells, responses were
classified as Th1, Th2 or “other” responses. CD4+ T cell responses
in children with IFN-g– but no IL-4–secreting CD4+ T cells were
defined as a Th1 response and CD4+ T cell responses in children
with IL-4– but no IFN-g–secreting T cells were defined as Th2
response. All other responses including a mixed Th1/Th2 response
were defined as “other” (Fig. 3A). There was no difference in the
proportion of children with either a dominant Th1 or Th2 response
to the DBLa-tag at the acute malaria episode. There were no sig-
nificant differences between the number of children inducing Th1
and Th2 responses with respect to parasite density or age at the time
of the acute episode. Children who induced a Th2 response had
a higher number of prior malaria episodes during their lifetime
compared with children who induced Th1 responses, a mixed re-
sponse or no response although the differences were not significant
Table I. Baseline parameters of children inducing T cell responses at the acute episode
Responders Non-Responders
n = 27 n = 8 p
Age at acute event (months) 66.5 (49.6–84.8) 68 (43.2–90.2) 0.783
Parasite density (iRBCx103/ml) 150 (73–222) 128 (19.3–232) 0.738
RBC (109/ml) 4.4 (4.1–4.8) 4.5 (4.4–4.8) 0.651
Hb (g/dl) 10.4 (9.6–10.9) 10.9 (10.4–12.6) 0.116
WBC (106/ml) 8.5 (6.9–11.4) 8.2 (7.6,9.1) 0.898
Eosinophils (103/ml) 0.13 (0.06–0.19) 0.09 (0.06–0.14) 0.508
Time to next episode (days) 249 (194.5–356) 199 (62.5–303.2) 0.276
TNFa (pg/ml) 0 (0,0) 0 (0–5.5) 0.159
IL-12 (pg/ml) 26.8 (0–115.9) 96.2 (9.6–198.4) 0.278
IL-10 (pg/ml) 726.6 (211–1666) 1041 (332–2355) 0.555
TGF-b (pg/ml) 639.9 (0–4008) 190.7 (0–3647) 0.638
IFN-g (pg/ml) 0 (0–38.8) 9.3 (0–22.3) 0.842
IL-4 (pg/ml) 0 (0–0) 0 (0–0) 0.208
Shown are median and 25th and 75th percentile. Differences between the groups were determined by Mann–Whitney U test.
FIGURE 3. Phenotype of CD4+ T cells stimulated with the homologous DBLa-tag. The phenotype of CD4+ T cell in response to the homologous DBLa-
tag was classified for each child as follows: Th1: IFN-g– but no IL-4–secreting CD4+ T cells; Th2: IL-4– but no IFN-g–secreting CD4 T cells; Other: All
other responses including mixed Th1/Th2 responses; No responses: children who did not induce any Ag-specific CD4+ T cells. (A) Shown are pie charts of
the proportion of all children who induced a given CD4+ T cell phenotype in response to the DBLa-tag at the acute episode (n = 35) and at the cross-
sectional survey in May 2009 (n = 26). (B) Number of episodes before the acute event in children with different CD4+ T cell phenotypes. Shown are median
(horizontal bar) and 25th and 75th percentile (vertical bars). The differences in the number of episodes in children with a dominant Th2 response compared
with the number of episodes in children with other responses were not significant.
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(Fig. 3B). As expected, there was a significant difference in the
median IFN-g plasma cytokine levels (median [25th–75th percentile]:
Th1 = 41.9pg/ml [10–105], Th2 = 0 pg/ml [0–0], Mann–Whitney
p = 0.0124) between children who induced a Th1 CD4 T cell re-
sponse and those that did not. There was no significant difference in
the mean IL-4 plasma cytokine concentration between children who
induced a dominant Th1 response (median [25th–75th percentile]:
0 pg/ml [0–0]) and those that induced a Th2 response (median
[25th–75th percentile]: 0 pg/ml [0–0]) due to the small number of
children with detectable levels of plasma IL-4.
Phenotype of T cell responses to PfEMP1 after the acute
malaria episode
We analyzed CD4+ T cell recall responses to the DBLa-tag rep-
resenting the dominant PfEMP1 expressed on the clinical isolate
during acute disease in 26 children from whom PBMCs had been
collected during the cross-sectional survey in May 2009 (Fig. 2B).
At the cross-sectional survey all but 9 children were free of parasites.
Parasite positive children were included in the analysis because they
did not present with any clinical symptoms and showed a similar
profile of CD4+ T cell responses to the homologous DBLa-tag as
parasite-free children (Supplemental Table I). The average number of
days between the acute event and collection of blood samples during
the cross-sectional survey was 235 d (CI 204–265). During the cross-
sectional survey, 62% (16/26) children mounted DBLa-tag specific
recall CD4+ T cell responses. Interestingly, children who showed
any DBLa-tag specific CD4+ T cell responses had lower parasite
densities at the acute episode than non-responders (Table II). This
was true for the 11 children who displayed DBLa-tag specific IL-4–
secreting CD4+ T cells (t = 2.83 p = 0.011) and the 14 children
inducing IL-2+–secreting CD4+ T cells (t test = 2.16 p = 0.040)
but not for those who induced IL-10– or IFN-g–secreting CD4+
T cells (n = 5 and n = 1, respectively).
When we compared the phenotypes of CD4+ T cell responses
induced during the acute episode with those induced during the
cross-sectional survey, we observed no significant differences in
the overall profile (Fig. 3A). However, the proportion of children
with DBLa-tag specific IFN-g–secreting CD4+ T cells signifi-
cantly dropped (Fisher’s exact test: acute n = 12, postacute n =
3, p = 0.0028).
CD4+ T cell responses during acute disease are associated
with specific subgroups of PfEMP1
We analyzed whether CD4+ T cell responses to the DBLa-tag
were associated with a specific subgroup of PfEMP1 as pre-
viously observed (24). DBLa-tags were grouped into those con-
taining 2 cyteines (cys2) and those containing 4 cysteines (cys4)
(Fig. 4A). Children harboring iRBCs dominantly expressing cys2
PfEMP1 (15/35) were more likely to induce IL-10–secreting
CD4+ T cells (n = 10, Odds Ratio 10.2 p = 0.006) than children
harboring iRBCs expressing non-cys2 PfEMP1 (Fig. 4B). By con-
trast, children harboring iRBCs dominantly expressing cys4
PfEMP1 (17/35) were more likely to induce CD4+ IFN-g+ T cells at
the acute episode (n = 9, Odds Ratio 6.8 p = 0.017) compared with
children harboring iRBCs expressing non-cys4 PfEMP1. In line
with the observations above, children infected with parasites
dominantly expressing a cys4 PfEMP1 had higher median pro-
portion of CD4+IFN-g+ T cells whereas those infected with para-
sites dominantly expressing a cys2 PfEMP1 had a higher median
proportion of CD4+IL-10+ T cells (Table III).
DBLa-tag specific IL-4–secreting CD4+ T cells are associated
with protection
We wondered whether either the phenotype of a CD4+ T cell
response or the PfEMP1 subgroup dominantly expressed by the
clinical isolate a child was infected with correlated with time to
Table II. Comparison of baseline parameters in children with or without DBLa-tag specific CD4 T cell
responses at the cross-sectional survey
Responder Non-Responder
n = 16 n = 10 p
Age at survey (months) 77.5 (60.7–96.7) 79.2(71.8–101.8) 0.527
Parasite density (iRBC 3 103/ml) acute 76.8 (16.2–129.1) 207.9 (169.5–293.2) 0.008
Parasite density (iRBC 3 103/ml) survey* 0 (0–0.54) 0 (0–19) 0.804
RBC (106/ml) 4.6 (4–4.8) 4.8 (4.6–4.9) 0.282
Hb (g/dL) 11.3 (11.1–11.8) 12.6 (12.5–12.7) 0.05
WBC (106 /ml) 8.2 (5.9–10.3) 5.7 (5.2–7) 0.09
Time from acute event (days) 267 (169–291) 276 (246–293) 0.477
Shown are median and 25th and 75th percentile. Differences between the groups were determined by Mann–Whitney U test.
Bold indicates statistically significant p values ,0.05.
*Nine children had low-level parasite densities (six responders and three non-responders). However, their data were not
excluded as they were all asymptomatic with a temperature of , 37.5˚C.
FIGURE 4. Relationship between CD4+ T cell responses to cys2 and cys4 PfEMP1. (A) Pie chart representing the proportion of recombinant DBLa-tags
falling into cys2 (PoLV group1-3), cys4 (PoLV group 4 and 5) or none (PoLV group 6) of these groups (16). (B) Odds ratios and 95% confidence intervals
are plotted for CD4+ T cells secreting a cytokine as indicated when children were infected parasites dominantly expressing either cys2 PfEMP1 (circle) or
cys4 PfEMP1 (triangle). Children infected with cys2 PfEMP1-expressing iRBCs were more likely to induce CD4+IL10+ responses whereas children
infected with cys4 PfEMP1-expressing iRBC were more likely to induce CD4+IFN-g+ T cell responses. *p , 0.05.
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subsequent malaria episode a child had over the next year thus
indicating association of a particular response with protection.
Cox regression (adjusted for age) showed that those children who
induced DBLa-tag specific IL-4+ CD4+ T cell responses during
the acute episode remained episode-free for longer (HR = 0.31,
CI 0.12–0.79, p = 0.014; test of proportional hazards assumption
x2 = 15.39 p = 0.0005) than children who induced DBLa-tag
specific CD4+ T cells secreting either IFN-g, IL-2 or IL-10 (HR =
0.56, CI 0.21–1.47, p = 0.243; HR = 0.51, CI 0.20–1.29, p = 0.152;
HR = 1.17, CI 0.517–2.66, p = 0.702) (Fig. 5). Of note, the ma-
jority of children who induced Th2 responses to the DBLa-tag
during the cross-sectional survey (8/26) remained episode free for
at least 7 mo after the acute event. In addition, children who induced
Th2 responses (n = 8) during acute malaria tended to have higher
number of total malaria episodes prior to the acute event (Fig. 3B)
than children who induced a Th1 response (odds = 1.45 p = 0.148;
adjusted for age at acute illness) although the difference was not
significant. Thus, induction and maintenance of Ag-specific IL-4+
CD4+ T cell responses are associated with protection independent
of the subgroup of PfEMP1 expressed on the acute isolate.
Ab responses to the homologous DBLa-tag
We determined the induction of IgG Abs to the DBLa-tag rep-
resenting the dominant expressed PfEMP1 on iRBCs isolated at
acute disease in each child by ELISA. In addition, we analyzed the
induction of IgG4 and IgE Abs to the DBLa-tag because the Ab
isotypes are associated with a classical Th2 response. The DBLa-
tag specific IgG Ab concentration increased from a median OD
value of 0 (25th and 75th percentile: 0–0.12) at acute disease to
a median OD value of 0.7 (25th and 75th percentile: 0.1–1.17) at
the cross-sectional survey. In total, 18 out of 31 children induced
IgG Abs to the homologous DBLa-tag between acute disease and
the cross-sectional survey whereas 13 children either did not in-
duce or lost their existing Ab response (Fig. 6). DBLa-tag specific
IgG4 and IgE Abs were low or not detectable in all children
(postacute median OD value [25th and 75th percentile] for IgG4:
0.0 [0–0.02], for IgE: 0.0 [0–0.047]). Two children induced
DBLa-tag specific IgG4 responses after the acute malaria episode
but neither child had induced IL-4–secreting CD4+ T cells. Only
in children who gained an IgG Ab response after the acute malaria
episode, we observed a weak positive correlation between the per-
centage of IL-10–producing CD4+ T cells at acute disease and
induction of DBLa-tag specific Ab responses to the homolo-
gous DBLa-tag (Spearman rho = 0.579, p = 0.0118) but not with
other cytokine-producing CD4+ T cells. IL-10 is a potent cytokine
for the induction of long-lived plasma cells, which may explain the
association between IL-10–secreting CD4+ T cells and induction of
Ab responses to the homologous DBLa-tag.
Discussion
The sequence diversity of PfEMP1 makes it difficult to analyze
immune responses to variants of this Ag expressed on clinical
isolates. Only a small region of the DBLa-domain of PfEMP1, the
DBLa-tag, can be targeted with universal primers amplifying al-
most all variants identified to date (16). We recently reported that
almost all children attending Kilifi District Hospital with acute
malaria induced CD4+ T cell responses to recombinant DBLa-
tags that were identified in the clinical isolate they were infected
with. Using the same system, we investigated the phenotype of
CD4+ T cells specific for the DBLa-tag identified in each clinical
isolate for 35 children suffering from acute malaria and who were
under active surveillance for acute malaria episodes. We show in
this article that children who induced DBLa-tag specific IL-4+
CD4+ T cell responses had a delayed time to subsequent malaria
episodes over the next year. These data suggest that DBLa-tag
specific CD4+IL-4+ T cells contribute to protection from future
malaria episodes.
Almost all children induced DBLa-tag specific CD4+ T cells
secreting any of the cytokines measured during the acute malaria
episode and 62% maintained effector cells for over 6 mo sug-
gesting that effector memory T cells had been induced. Interestingly,
the proportion of children who maintained Ag-specific IFN-g–
secreting CD4+ T cells had dropped significantly at the cross-
sectional survey. We confirmed our previous observation (24) that
children suffering from acute malaria and infected with clinical
isolates that dominantly expressed cys2 PfEMP1 were more likely
to induce IL-10–secreting CD4+ T cells during acute disease. By
contrast, children infected with clinical isolates dominantly ex-
pressing cys4 PfEMP1 were more likely to induce IFN-g–secreting
CD4+ T cells. We did not observe the later association in children
attending Kilifi District Hospital with acute malaria even though
Table III. Comparison of CD4 T cell responses to cys2 and cys4
PFEMP1
Cys2 Cys4 p
CD4+IFN-g+ (%) 0 (0–0) 0.04 (0–0.173) 0.027
CD4+IL-10+ (%) 0.033 (0–0.08) 0 (0–0) 0.0021
CD4+IL2+ (%) 0 (0–0.06) 0.04 (0–0.14) 0.324
CD4+IL-4+ (%) 0 (0–0.32) 0.034 (0–0.038) 0.699
Shown are median 25th and 75th percentile. Differences in the percentage of CD4+
T cells secreting cytokines as indicated were determined by Mann–Whitney U test.
Bold indicates statistically significant p value ,0.05.
FIGURE 5. Survival plots with time to first episode of clinical malaria
over a 12 mo period. Survival plots for children who induced DBLa-tag
specific CD4+ T cells secreting a given cytokine. Children who made
a CD4+IL-4+ T cell response (n = 14) remained episode free longer than
children who did not (HR = 0.31, CI 0.12–0.79, p = 0.014, adjusted for
age). Hazard ratios for all other types of T cell responses were not sig-
nificant. *Log rank test for equality.
FIGURE 6. Ab responses to the homologous DBLa-tag at the acute
episode and the cross-sectional survey. Shown are corrected OD values of
DBLa-tag specific Ab responses for each child at the time of acute disease
and at the cross-sectional survey for IgG, Ig4, and IgE.
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the majority of these children did not suffer from severe, life-
threatening malaria (24). The reasons for this discrepancy are un-
known but children attending the Kilifi District Hospital tended to
be younger and showed higher parasite density. It is possible that
they were more severely ill due to later detection of parasites or
that they failed to mount an adequate immune response to cys4
PfEMP1 or both. In humans, several studies reported an association
of IFN-g production by CD4+ T cells but also NK and gd T cells
with protection from symptomatic malaria (reviewed in Ref. 29).
Furthermore, experimentally infected volunteers and Thai adults
living in a low-transmission area maintained IFN-g–secreting ef-
fector memory T cells for at least a year (30, 31). However, other
studies indicated that downregulation of IFN-g responses occurred
in individuals repeatedly exposed to malaria (32–34) but re-
emerged when previously immune individuals were no longer
exposed (35). Together these data suggest that IFN-g–production
by Th1 cells and other lymphocytes may be important for control
of parasitaemia in individuals with low immunity for instance
through activation of cellular responses. With increasing exposure
and acquisition of Ab responses to a range of malarial Ags, effi-
cient T cell help for B cells might be more important for clinical
immunity to malaria.
In this study, we observed a clear association of IL-4–producing
T cells specific for DBLa-tags with prolonged time to reinfection
and clinical malaria. Interestingly, children who maintained IL-4–
producing responses to the DBLa-tag tended to have a higher rate
of past exposure but lower parasitaemia during the acute disease
than those children inducing other T cell responses. Studies in an-
imal models of malaria demonstrated that protection from malaria is
dependent on both Th1 and Th2 responses. In these models, early
induction of IFN-g–producing CD4+ T cells was required for the
control of parasitaemia through activation of innate immune re-
sponses whereas clearance of parasites was dependent on the in-
duction of Th2 T cells and the presence of B cells (36, 37). Studies
conducted in humans demonstrated that Ag-specific IL-4+ producing
T cells were associated with elevated levels of malaria-specific serum
IgG (38) and that Th1 cytokines were dominant at acute disease
followed by a Th2 response during parasite clearance (39, 40). The
proportion of individuals with IL-4–producing lymphocytes in
responses to parasite Ag was higher among the Fulani, who are more
resistant to malaria, than the sympatric group of Dogon (41). In
addition, Th2 responses to malarial Ags have been studied in
the context of polymorphisms in the IL-4 promoter region affecting
the production of IL-4. Several studies showed that polymorphism
in the IL-4 promoter region were associated with either protection or
susceptibility to severe disease in populations living under different
transmission intensities (42–44). In addition, Th2-dependent in-
duction of Ag-specific IgE has been reported in some studies and
associated with both protection (45) and susceptibility to malaria
(46). In summary, although the relative importance of Th2 re-
sponses in human malaria remains somewhat elusive the available
evidence suggests that both late during a single infection as well
as with repeated infection, IL-4–secreting T cells increase whereas
IFN-g–producing CD4+ T cells decrease (47) as has been shown
in mouse models of malaria.
T cells provide help to B cells through differential expression of
costimulatory molecules thus driving activation and differentiation
of B cells, but also require reciprocal activation by B cells for
differentiation. The main role of CD4+ Th cells in tissues and
peripheral circulation is probably to activate innate cellular
responses in a pathogen specific manner whereas follicular helper
T cells (Tfh) producing IL-21 are now considered the main T cell
subset providing help to B cell (reviewed in Ref. 48). Both, Tfh and
Th2 cells can produce IL-4 and thus IL-4 production by T cells
can occur in a Th2-independent manner and, in line with the in-
creasing recognition of T cell plasticity, exert different functions
dependent on location and cellular context (49).
IL-21 and IL-4 have largely overlapping roles in the induction of
the germinal center reaction and Ab responses. More specifically
IL-4 is important for somatic hypermutation, class switching as
it promotes isotype switching to all IgG subclasses (50, 51) and
induction of memory B cell differentiation (52). By contrast, IL-
21 and, to a lesser extent, IL-10 is critical for the induction and
survival of plasma cells (53–55).
To establish whether DBLa-tag specific CD4+IL-4+ were asso-
ciated with induction of Ag-specific Abs, we measured DBLa-tag
specific total IgG as well as IgG4 and IgE in plasma from acute
and cross-sectional samples. We did not observe a correlation
between IL-4–secreting T cells and DBLa-tag-specific Abs in
plasma at the time of the cross-sectional survey for any of the Ab
subclasses measured.
Therefore, at least in our study, IL-4 secretion by Ag-specific
T cells was not associated with increased plasma concentration
of DBLa-tag-specific Abs. It has been reported recently that PBMCs
from malaria immune donors produced IL-21 and that increased
plasma concentration of IL-21 correlated with Ag-specific IgG1 and
IgG3 concentrations and (56, 57). Given the differential role of IL-4
and IL-21 for memory or plasma cell differentiation respectively, it
seems likely that IL-4–secreting CD4+ T cells promoted the in-
duction of DBLa-tag specific memory B cells rather than long-lived
plasma cells. Indeed, it has been repeatedly reported that in children,
Abs to malarial Ags rapidly decline and are maintained only in the
presence of parasites (58–60) whereas memory B cells are in-
duced and maintained even in the absence of exposure for several
years (61, 62). Further studies analyzing the relationship between
Ag-specific memory B cells, Ab levels and different CD4+ T cell
subsets including Th2 and Tfh T cells are required to elucidate these
interactions and their relevance for clinical immunity to malaria
in humans.
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